Intrinsic Value of S&P & Nasdaq Contact Us

Filament Health Corp. FLHLF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
29/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Filament Health Corp. (FLHLF) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 28/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
29/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
46/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — FLHLF

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.04
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.02
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2020 $0.00 $0.00 $-191.1K -
2021 $-0.06 $0.00 $-9.25M -
2022 $-0.10 $364.5K $-16.47M -4517.5%
2023 $-0.03 $2.13M $-5.32M -249.7%
2024 $-0.02 $616.68K $-4.97M -806%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message